Schedule 13D ownership disclosure
Phathom Pharmaceuticals Inc
Security class unavailable · CUSIP: 71722W107
Event date: 2024-04-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,790,480
- Percent of class
- 4.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001395064-24-000025
- Form type
- SC 13D
- Filer
- Phathom Pharmaceuticals, Inc.
- CIK
- CIK 1783183
- Filed
- Apr 10, 2024
- Reporting period
- Apr 09, 2024
- Description
- Schedule 13D beneficial ownership